多瑞医药
(301075)
| 流通市值：45.99亿 | | | 总市值：45.99亿 |
| 流通股本：8000.00万 | | | 总股本：8000.00万 |
| 报告期 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 253,435,579.28 | 227,644,668.85 | 278,182,353.51 | 262,128,315.39 |
| 交易性金融资产 | 80,000,000 | 105,128,000 | 110,999,407.78 | 141,682,852.5 |
| 应收票据及应收账款 | 82,485,444.04 | 116,519,723.35 | 100,473,385.27 | 105,956,370.45 |
| 其中：应收票据 | 2,043,486.57 | 9,872,950.31 | - | 3,063,166.09 |
| 应收账款 | 80,441,957.47 | 106,646,773.04 | 100,473,385.27 | 102,893,204.36 |
| 应收款项融资 | 289,849.45 | 0 | 249,016.16 | 1,983,141.16 |
| 预付款项 | 45,398,558.18 | 36,080,572.68 | 39,625,417.6 | 31,648,271.16 |
| 其他应收款合计 | 10,500,738.75 | 9,699,404.63 | 20,594,260.53 | 19,546,596.23 |
| 存货 | 65,000,001.7 | 49,223,515.33 | 59,104,491.82 | 45,848,529.26 |
| 其他流动资产 | 23,135,868.58 | 20,919,255.54 | 22,620,891.52 | 21,958,877.68 |
| 流动资产合计 | 560,246,039.98 | 565,215,140.38 | 631,849,224.19 | 630,752,953.83 |
| 非流动资产: | | | | |
| 长期股权投资 | 26,232,835.39 | 29,460,396.95 | 29,843,803.19 | 29,843,803.19 |
| 其他权益工具投资 | 82,671,764.17 | 78,337,950 | 78,337,950 | 78,337,950 |
| 固定资产 | 622,357,697.28 | 630,227,765.84 | 622,611,252.64 | 636,670,944.35 |
| 在建工程 | 18,820,697.95 | 12,268,042.95 | 8,453,907.84 | 5,665,124.1 |
| 使用权资产 | 8,738,403.04 | 9,314,519.37 | 10,466,752.03 | 10,466,752.03 |
| 无形资产 | 77,582,008.81 | 77,766,630.99 | 78,229,838.58 | 78,477,274.65 |
| 开发支出 | 0 | - | - | - |
| 商誉 | 19,036,564.15 | 19,096,653.78 | 19,156,743.4 | 19,216,833.03 |
| 长期待摊费用 | 4,289,998.35 | 2,739,800 | 2,826,262.95 | 2,835,813.73 |
| 递延所得税资产 | 2,904,349.73 | 1,770,222.12 | 3,093,625.07 | 3,085,790.36 |
| 其他非流动资产 | 24,468,841.32 | 24,458,593.32 | 37,626,182.44 | 39,635,784.65 |
| 非流动资产合计 | 887,103,160.19 | 885,440,575.32 | 890,646,318.14 | 904,236,070.09 |
| 资产总计 | 1,447,349,200.17 | 1,450,655,715.7 | 1,522,495,542.33 | 1,534,989,023.92 |
| 流动负债: | | | | |
| 短期借款 | 97,736,712.32 | 97,947,315.17 | 65,935,857.64 | 67,952,297.39 |
| 应付票据及应付账款 | 70,888,791.29 | 46,039,685.95 | 49,465,851.91 | 58,135,609.74 |
| 应付账款 | 70,888,791.29 | 46,039,685.95 | 49,465,851.91 | 58,135,609.74 |
| 预收款项 | 0 | - | 1,911,733.82 | 1,250,000 |
| 合同负债 | 4,867,067.49 | 2,538,984.8 | 995,365.13 | 2,777,894.79 |
| 应付职工薪酬 | 3,872,578.6 | 3,693,756.23 | 3,807,263.3 | 8,014,207.88 |
| 应交税费 | 907,492.49 | 437,624.1 | 2,732,781.22 | 2,309,038.45 |
| 其他应付款合计 | 232,381,836.43 | 234,341,389.79 | 247,110,540.1 | 247,291,587.7 |
| 一年内到期的非流动负债 | 70,235,370.8 | 70,711,843.41 | 117,766,731.08 | 118,239,863.95 |
| 其他流动负债 | 70,960.1 | 82,332.17 | 104,869.16 | 3,399,764.08 |
| 流动负债合计 | 480,960,809.52 | 455,792,931.62 | 489,830,993.36 | 509,370,263.98 |
| 非流动负债: | | | | |
| 长期借款 | 197,000,000 | 167,500,000 | 167,500,000 | 137,500,000 |
| 租赁负债 | 5,938,643.58 | 6,514,759.91 | 7,666,992.57 | 7,213,367.57 |
| 递延收益 | 102,415,662.36 | 104,215,954.86 | 106,265,503.86 | 106,897,124.32 |
| 递延所得税负债 | 20,355,048.24 | 20,415,137.87 | 20,475,227.49 | 20,535,317.12 |
| 其他非流动负债 | 0 | - | - | - |
| 非流动负债合计 | 325,709,354.18 | 298,645,852.64 | 301,907,723.92 | 272,145,809.01 |
| 负债合计 | 806,670,163.7 | 754,438,784.26 | 791,738,717.28 | 781,516,072.99 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 80,000,000 | 80,000,000 | 80,000,000 | 80,000,000 |
| 资本公积 | 506,845,981.73 | 506,941,221.73 | 506,941,221.73 | 506,941,221.73 |
| 减:库存股 | 20,991,708.87 | 20,991,708.87 | 20,991,708.87 | 20,991,708.87 |
| 其他综合收益 | 1,137,272.68 | 1,137,272.68 | 1,137,272.68 | 1,137,272.68 |
| 盈余公积 | 20,260,274.89 | 20,260,274.89 | 20,260,274.89 | 20,260,274.89 |
| 一般风险准备 | 0 | - | - | - |
| 未分配利润 | 9,655,922.61 | 46,880,045.91 | 73,785,443.94 | 89,383,609.72 |
| 归属于母公司股东权益合计 | 596,907,743.04 | 634,227,106.34 | 661,132,504.37 | 676,730,670.15 |
| 少数股东权益 | 43,771,293.43 | 61,989,825.1 | 69,624,320.68 | 76,742,280.78 |
| 股东权益合计 | 640,679,036.47 | 696,216,931.44 | 730,756,825.05 | 753,472,950.93 |
| 负债和股东权益合计 | 1,447,349,200.17 | 1,450,655,715.7 | 1,522,495,542.33 | 1,534,989,023.92 |
| 公告日期 | 2025-10-24 | 2025-08-27 | 2025-04-25 | 2025-04-18 |
| 审计意见(境内) | | | | 标准无保留意见 |